Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) ir indicēts pamatskolu un pastiprinātājs vakcinācija zīdaiņiem un maziem bērniem no sešu nedēļu vecumam pret difterija, stingumkrampji, garais klepus, b hepatīts, poliomielīta un invazīvajām slimībām, ko izraisa haemophilus influenzae tips b (hib). izmantojot šo vakcīnu, kas būtu saskaņā ar oficiālās rekomendācijas.

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningīts, meningokoku - vakcīnas - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vakcīnas - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 un 5. 1 in product information document). izmantojot šo vakcīnu, kas būtu saskaņā ar oficiālās rekomendācijas.

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripas, cilvēka - vakcīnas - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi winthrop industrie, france - zolpidēma tartrāts - apvalkotā tablete - 10 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi-aventis latvia, sia, latvija - betaksolola hidrohlorīds - apvalkotā tablete - 20 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi winthrop industrie, france - alfuzosīna hidrohlorīds - ilgstošās darbības tablete - 10 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi b.v., netherlands - imūbnglobulīns pret cilvēka timocītiem, truša - pulveris infūziju šķīduma pagatavošanai - 25 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi winthrop industrie, france - spiramicīns - apvalkotā tablete - 3 miljoni sv

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanofi-aventis groupe, france - pentoksifilīns - ilgstošās darbības tablete - 400 mg